Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.3675
-0.0199 (-5.14%)
At close: Aug 29, 2025, 4:00 PM
0.3700
+0.0025 (0.68%)
After-hours: Aug 29, 2025, 7:57 PM EDT

Clearside Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
29727367164132
Upgrade
Market Cap Growth
-36.01%-1.32%8.31%-58.91%23.85%11.02%
Upgrade
Enterprise Value
76988646140120
Upgrade
Last Close Price
0.370.951.171.122.752.74
Upgrade
PE Ratio
----436.39-
Upgrade
PS Ratio
6.7443.308.8850.805.5516.78
Upgrade
PB Ratio
--1.85-4.596.364.3215.12
Upgrade
P/TBV Ratio
---6.364.3215.12
Upgrade
EV/Sales Ratio
18.1759.1610.4634.954.7215.16
Upgrade
Debt / Equity Ratio
-1.15-1.35-2.703.320.020.23
Upgrade
Asset Turnover
0.170.060.190.030.950.34
Upgrade
Quick Ratio
3.354.284.318.358.721.74
Upgrade
Current Ratio
3.874.444.428.549.081.82
Upgrade
Return on Equity (ROE)
----135.63%1.61%-182.83%
Upgrade
Return on Assets (ROA)
-55.45%-61.04%-36.40%-40.17%-1.26%-48.63%
Upgrade
Return on Capital (ROIC)
-101.90%-88.70%-42.56%-44.78%-1.59%-79.19%
Upgrade
Earnings Yield
-96.05%-47.68%-44.49%-48.87%0.23%-13.74%
Upgrade
FCF Yield
-77.05%-35.63%-27.27%-20.19%-6.54%-9.94%
Upgrade
Buyback Yield / Dilution
-13.54%-19.41%-2.66%-0.50%-28.81%-21.84%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q